Department of Clinical Laboratory, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China.
Department of Clinical Laboratory, Beijing Chao-yang Hospital, Capital Medical University, Beijing, China.
Clin Chim Acta. 2025 Jan 15;565:120021. doi: 10.1016/j.cca.2024.120021. Epub 2024 Nov 1.
Serum homocysteine (Hcy) measurement accuracy is essential for detecting and diagnosing cardio-cerebrovascular illnesses. Although many different methods have been developed to determine the concentration of Hcy, those different assays showed nonequivalent results. This study aimed to develop an accurate and precise isotope dilution liquid chromatography-tandem mass spectrometry (ID-LC/MS/MS) method for serum homocysteine (Hcy) and assign values for reference materials used in external quality assessment (EQA) programs.
Different concentrations of homocysteine calibration solutions were prepared with d4-Hcy as the internal standard. This method employed DTT to reduce protein-bound Hcy, followed by protein precipitation, and gradient elution on a Supelcosil LC-CN column for chromatographic separation, and multiple reaction monitor (MRM) mode with electrospray ionization (ESI) for mass spectrometric detection. After optimized ID-LC/MS/MS parameters, imprecision, trueness, the limit of quantification (LoQ), the limit of detection (LoD), and measurement uncertainty were evaluated to check the methodological performance. The established method was employed in assigning values to EQA samples, which were sent to 63 clinical laboratories in Beijing to measure Hcy.
At 10.69,15.99, and 37.80 μmol/L levels, the present method demonstrated analytical imprecision of 0.57 %, 0.65 %, and 0.57 %, and recoveries of 99.67 % to 100.21 %, respectively. The bias between the target values of GBW (Guojia Biaozhun Wuzhi) were - 0.79 % to 0.62 %. The LoQ and LoD for Hcy were 0.36 nmol/L and 0.27 nmol/L. The method had an uncertainty (U 95 %) of 1.34 % to 1.48 %. For the three levels of EQA samples, the percentage of laboratories meeting the trueness evaluation criteria (±10 %) was 81.67 %, 83.33 %, and 71.67 % respectively.
With optimal method precision and trueness, the ID-LC/MS/MS method to measure serum Hcy can be used for value assignment of EQA samples, which can provide reliable data for monitoring the accuracy of clinical laboratory for Hcy measurement.
血清同型半胱氨酸(Hcy)的测量准确性对于检测和诊断心脑血管疾病至关重要。尽管已经开发出许多不同的方法来测定 Hcy 的浓度,但这些不同的检测方法并未得到等同的结果。本研究旨在建立一种准确且精密的同位素稀释液相色谱-串联质谱(ID-LC/MS/MS)法来测定血清同型半胱氨酸(Hcy),并为外部质量评估(EQA)计划中的参考物质赋值。
采用内标 d4-Hcy 制备不同浓度的同型半胱氨酸校准溶液。该方法采用 DTT 还原蛋白结合型 Hcy,然后进行蛋白沉淀,在 Supelcosil LC-CN 柱上进行梯度洗脱进行色谱分离,采用电喷雾电离(ESI)的多反应监测(MRM)模式进行质谱检测。在优化了 ID-LC/MS/MS 参数后,评估精密度、准确度、定量下限(LoQ)、检测下限(LoD)和测量不确定度,以检查方法性能。将建立的方法用于赋值 EQA 样本,将 EQA 样本发送到北京的 63 个临床实验室进行 Hcy 测量。
在 10.69、15.99 和 37.80 μmol/L 水平下,本方法的分析精密度分别为 0.57%、0.65%和 0.57%,回收率分别为 99.67%至 100.21%。GBW(国家标准物质)目标值的偏差为-0.79%至 0.62%。Hcy 的 LoQ 和 LoD 分别为 0.36 nmol/L 和 0.27 nmol/L。该方法的不确定度(U95%)为 1.34%至 1.48%。对于三个水平的 EQA 样本,符合准确度评价标准(±10%)的实验室比例分别为 81.67%、83.33%和 71.67%。
本研究建立的 ID-LC/MS/MS 方法用于测定血清 Hcy,具有最佳的方法精密度和准确度,可用于 EQA 样本的赋值,为监测临床实验室 Hcy 测量的准确性提供可靠数据。